Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Madrid Spain (1986)

Organization Overview

First Clinical Trial
2002
NCT00202774
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 2)

Carcinoma (Phase 2)

Colorectal Neoplasms (Phase 3)

Esophageal Neoplasms (Phase 2)

Hypersensitivity (Phase 2)

Neoplasm Metastasis (Phase 2)

Neoplastic Cells, Circulating (Phase 2)

Pancreatic Neoplasms (Phase 2)

Rectal Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 27
  • # of Trial APIs: 18